Allergan Finance, LLC Credit Rating

Resultados 1 - 50 de 86

Página de 2 Next

Filtrar por:

Fecha	Tipo de Informe	Título	Fuente
22 May 2020	Rating Action	Moody's withdraws Allergan's ratings	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Allergan, Inc.	Moody's Investors Service
25 Oct 2019	Rating Action	Moody's assigns Baa2 to AbbVie's exchange note offering	Moody's Investors Service
26 Jun 2019	Credit Opinion	Allergan Plc: Update to credit analysis – acquisition by AbbVie is pending	Moody's Investors Service
25 Jun 2019	Rating Action	Moody's reviews Allergan's Baa3 ratings for upgrade	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Allergan, Inc.	Moody's Investors Service
07 Nov 2018	Credit Opinion	Allergan Plc: Update to credit analysis – near term earnings pressure, but solid pipeline	Moody's Investors Service
30 Oct 2018	Announcement	Moody's: Allergan's debt reduction credit positive	Moody's Investors Service
30 Oct 2018	Issuer Comment	Allergan plc: Debt reduction credit positive	Moody's Investors Service
20 Apr 2018	Announcement	Moody's: Allergan's strategic review increases event risk	Moody's Investors Service
14 Feb 2018	Credit Opinion	Allergan plc: Updated to credit analysis – near term generic pressures, tempered by strong pipeline	Moody's Investors Service
06 Apr 2017	Credit Opinion	Allergan Plc: Updated Discussion of Key Credit Factors	Moody's Investors Service
02 Nov 2016	Announcement	Moody's: Allergan's Share Repurchase and Dividend Announcement are Credit Negative: No Impact to Ratings	Moody's Investors Service
02 Nov 2016	Issuer Comment	Allergan Plc: Allergan’s Share Repurchase and Dividend Announcement are Credit Negative: No Impact to Ratings	Moody's Investors Service
11 May 2016	Announcement	Moody's: Allergan's Share Repurchase Announcement is Credit Negative	Moody's Investors Service
11 May 2016	Issuer Comment	Allergan Plc: Allergan’s Share Repurchase Announcement is Credit Negative	Moody's Investors Service
14 Apr 2016	Issuer In-Depth	Allergan Plc: After Generics Sale, Allergan Won't Sit on its Cash for Long	Moody's Investors Service
08 Apr 2016	Credit Opinion	Allergan Plc: Update to Allergan's Key Rating Factors Following Termination of Pfizer Deal	Moody's Investors Service
06 Apr 2016	Rating Action	Moody's confirms Allergan's Baa3 rating; outlook stable	Moody's Investors Service
23 Nov 2015	Rating Action	Moody's reviews Allergan's ratings for upgrade	Moody's Investors Service
27 Jul 2015	Rating Action	Moody's affirms Allergan's Baa3 rating, outlook stable	Moody's Investors Service
23 Jun 2015	Credit Opinion	Allergan Plc	Moody's Investors Service
17 Jun 2015	Rating Action	Moody's affirms Allergan's Baa3 rating; outlook is stable	Moody's Investors Service
22 Apr 2015	Rating Action	Moody's downgrades bonds of Allergan to Baa3	Moody's Investors Service
02 Mar 2015	Rating Action	Moody's assigns Baa3 rating to Actavis' senior notes	Moody's Investors Service
25 Feb 2015	Credit Focus	Global Pharmaceuticals: Actavis' Performance On-Track Ahead of $22B Bond Offering for Allergan	Moody's Investors Service
20 Nov 2014	Issuer Comment	Actavis' Allergan Deal Significantly Raises Leverage, but Brings Scale and Diversity Benefits	Moody's Investors Service
18 Nov 2014	Credit Focus	US Pharmaceuticals: Actavis Inc: Allergan Deal Adds Significant Debt, But Business Profile Supports Investment Grade
17 Nov 2014	Rating Action	Moody's Affirms Actavis' Baa3 rating on Allergan acquisition; Outlook stable	Moody's Investors Service
07 Oct 2014	Announcement	Moody's: Actavis' deal for Durata strategically sound but signals continued M&A risk	Moody's Investors Service
07 Oct 2014	Issuer Comment	: Actavis' Deal for Durata stategically sound but signals continued M&A risk	Moody's Investors Service
25 Aug 2014	Announcement	Moody's: Indian pharmaceutical sector to see strong growth	Moody's Investors Service
12 Aug 2014	Credit Focus	Actavis: With Modest Organic Revenue Growth, Cost-Cutting Will Drive EBITDA	Moody's Investors Service
10 Jun 2014	Credit Focus	Actavis: All Baa3-Debt is Not Created Equal	Moody's Investors Service
01 May 2014	Issuer Comment	Forest's Acquisition of Furiex Is Credit Negative for Actavis	Moody's Investors Service
28 Apr 2014	Announcement	Moody's: Forest Lab's acquisition of Furiex is Credit Negative for Actavis	Moody's Investors Service
28 Apr 2014	Issuer Comment	Forest Lab's acquisition of Furiex is Credit Negative for Actavis	Moody's Investors Service
24 Feb 2014	Issuer Comment	Actavis Deal to Buy Forest Raises Its Leverage and Integration Risk	Moody's Investors Service
18 Feb 2014	Credit Focus	Actavis Inc.: Forest Labs Acquisition Is Riskier Than Warner Chilcott Deal	Moody's Investors Service
18 Feb 2014	Rating Action	Moody's Affirms Actavis' Baa3; stable outlook	Moody's Investors Service
20 Nov 2013	Credit Focus	Teva: Copaxone Threat Puts A3 Rating at Risk	Moody's Investors Service
08 Oct 2013	Credit Opinion	Actavis, Inc.	Moody's Investors Service
02 Oct 2013	Announcement	Correction to Text, October 1, 2013 Release: Moody's Affirms Actavis' Ratings; Upgrades Warner Chilcott's Senior Notes to Baa3	Moody's Investors Service
01 Oct 2013	Rating Action	Moody's Affirms Actavis' Ratings; Upgrades Warner Chilcott's Senior Notes to Baa3	Moody's Investors Service
24 Jun 2013	Issuer Comment	US Supreme Court's Pay-for-Delay Ruling Is Credit Negative for Pharma Firms	Moody's Investors Service
18 Jun 2013	Announcement	Moody's: Supreme Court Ruling Increases Legal Risk and Uncertainty for Generic Pharma Firms	Moody's Investors Service
27 May 2013	Issuer Comment	Actavis' All-Stock Deal for Warner Chilcott Will Decrease Leverage and Improve Cash Flow	Moody's Investors Service
24 May 2013	Announcement	Correction to Text, May 20, 2013 Release: Moody's Affirm's Actavis' Baa3; outlook stable	Moody's Investors Service
23 May 2013	Credit Focus	Actavis' Purchase of Warner Chilcott Is Rare Win-Win for Shareholders and Creditors	Moody's Investors Service
20 May 2013	Rating Action	Moody's Affirm's Actavis' Baa3; outlook stable	Moody's Investors Service

Resultados 1 - 50 de 86

Página de 2 Next

Informes & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: